The Immune Response Corporation

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 1254
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C07K PEPTIDES 1135

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
6328976 Non-infectious, protease defective HIV particles and nucleic acid molecules encoding thereforApr 03, 98Dec 11, 01[A61K]
5744326 Use of viral CIS-acting post-transcriptional regulatory sequences to increase expression of intronless genes containing near-consensus splice sitesMar 11, 96Apr 28, 98[C07H, C12N]
5256767 Retroviral antigensNov 10, 92Oct 26, 93[C12N, C07K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2005/0266,015 Enhanced activity of HIV vaccine using a second generation immunomodulatory oligonucleotideAbandonedMar 11, 05Dec 01, 05[A61K]
2005/0196,411 Immunogenic HIV compositions and related methodsAbandonedAug 27, 04Sep 08, 05[A61K]
6737066 HIV immunogenic compositions and methodsExpiredMay 05, 00May 18, 04[A61K]
2004/0002,466 Targeted delivery of genes encoding interferonAbandonedNov 26, 01Jan 01, 04[A61K]
6642028 Vectors and genes exhibiting increased expressionExpiredDec 04, 98Nov 04, 03[C12P, C12N]
2003/0134,420 Methods and compositions for gene deliveryAbandonedAug 02, 02Jul 17, 03[A61K, C12N]
2003/0108,517 Membrane-bound cytokine compositions and methods of modulating an immune response using sameAbandonedAug 19, 02Jun 12, 03[A61K]
6557296 Non-infectious, protease defective HIV particles and nucleic acid molecules encoding thereforExpiredJul 30, 01May 06, 03[C07H, A61K, C12Q, C12N]
2003/0072,751 IDIOTYPIC VACCINATION AGAINST B CELL LYMPHOMAAbandonedMar 14, 90Apr 17, 03[A61K, A01N, C12N]
2003/0044,428 Method for treating an HIV-infected individual by combining immunization with structured interruption of anti-retroviral treatmentAbandonedJan 24, 02Mar 06, 03[A61K]
6482407 Membrane-bound cytokine compositions comprising GM-CSF or an active fragment thereof and methods of modulating and an immune response using the sameExpiredMay 01, 01Nov 19, 02[A61K]
6464978 Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populationsExpiredApr 29, 93Oct 15, 02[A61K]
6413516 Peptides and methods against psoriasisExpiredJan 14, 94Jul 02, 02[A61K]
2002/0006,413 Genetically engineered tumor cell vaccinesAbandonedJan 26, 01Jan 17, 02[A61K]
6331525 Targeted delivery of genes encoding interferonExpiredAug 23, 99Dec 18, 01[A61K, C12N]
6221352 Method of preventing the proliferation of V.beta.14 or V.beta.17-Expressing T cellsExpiredJun 06, 95Apr 24, 01[A61K, C07K]
6207645 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populationsExpiredJul 18, 94Mar 27, 01[A61K]
6159470 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populationsExpiredJun 05, 95Dec 12, 00[A61K]
6113903 Peptides and methods against diabetesExpiredFeb 14, 94Sep 05, 00[A61K]
6090387 Vaccination and methods against diseases resulting from pathogenic responsesExpiredJun 06, 95Jul 18, 00[C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.